Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dougados

Showing results (331-340 of 362) with videos related to

Pageof 37
Sort By:
Annals of the Rheumatic Diseases|April 15, 2004
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedL B A van de Putte, C Atkins, M Malaise, et al.
Annals of the Rheumatic Diseases|February 9, 2006
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitisT Pham, R Landewé, S van der Linden, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritisM M Schoels, J Braun, M Dougados, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Autoimmunity Reviews|December 25, 2010
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseasesS van Assen, O Elkayam, N Agmon-Levin, et al.
Annals of the Rheumatic Diseases|November 27, 2010
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in generalM Rudwaleit, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Annals of the Rheumatic Diseases|August 21, 2007
The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritisH I Keen, F Lavie, R J Wakefield, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Annals of the Rheumatic Diseases|June 7, 2015
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registryJ H Salmon, J E Gottenberg, P Ravaud, et al.
Pageof 37

Showing results (331-340 of 362) with videos related to

Sort By:
Pageof 37
Annals of the Rheumatic Diseases|April 15, 2004
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedL B A van de Putte, C Atkins, M Malaise, et al.
Annals of the Rheumatic Diseases|February 9, 2006
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitisT Pham, R Landewé, S van der Linden, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritisM M Schoels, J Braun, M Dougados, et al.
Clinical and Experimental Rheumatology|September 13, 2011
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximabF Heldmann, J Brandt, I E van der Horst-Bruinsma, et al.
Autoimmunity Reviews|December 25, 2010
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseasesS van Assen, O Elkayam, N Agmon-Levin, et al.
Annals of the Rheumatic Diseases|November 27, 2010
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in generalM Rudwaleit, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Annals of the Rheumatic Diseases|August 21, 2007
The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritisH I Keen, F Lavie, R J Wakefield, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Annals of the Rheumatic Diseases|June 7, 2015
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registryJ H Salmon, J E Gottenberg, P Ravaud, et al.
Pageof 37